Insulin Aspart (Vials) (Fiasp) and Sarilumab Subcutaneous
Determining the interaction of Insulin Aspart (Vials) (Fiasp) and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart (Vials) (Fiasp)-Sarna Hc Topical application
- Insulin Aspart (Vials) (Fiasp)-Sarnol-HC
- Insulin Aspart (Vials) (Fiasp)-Sarnol-HC Maximum Strength
- Insulin Aspart (Vials) (Fiasp)-SAStid
- Insulin Aspart (Vials) (Fiasp)-Sastid Soap Topical
- Insulin Aspart (Vials) (Fiasp)-SAStid Topical
- Sarilumab Subcutaneous-Insulin aspart and insulin aspart protamine
- Sarilumab Subcutaneous-Insulin aspart and insulin degludec Subcutaneous
- Sarilumab Subcutaneous-Insulin Aspart Injection
- Sarilumab Subcutaneous-Insulin Aspart Protamine and Insulin Aspart
- Sarilumab Subcutaneous-Insulin aspart protamine and insulin aspart Subcutaneous
- Sarilumab Subcutaneous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)